KWELLADA-P CRÈME RINSE LIQUID

Country: Kanada

Bahasa: Inggeris

Sumber: Health Canada

Bahan aktif:

PERMETHRIN

Boleh didapati daripada:

MEDTECH PRODUCTS INC

Kod ATC:

P03AC04

INN (Nama Antarabangsa):

PERMETHRIN

Dos:

1%

Borang farmaseutikal:

LIQUID

Komposisi:

PERMETHRIN 1%

Laluan pentadbiran:

TOPICAL

Unit dalam pakej:

50ML/200ML

Jenis preskripsi:

OTC

Kawasan terapeutik:

SCABICIDES AND PEDICULICIDES

Ringkasan produk:

Active ingredient group (AIG) number: 0120085001; AHFS:

Status kebenaran:

APPROVED

Tarikh kebenaran:

2012-06-11

Ciri produk

_Kwellada-P Crèm_
_e Rinse _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_Page 1 of 14_
PRODUCT
MONOGRAPH
KWELLADA-P CREME
RINSE
Permethrin Crème Rinse 1%
w/w
Topical Pediculicide and
Ovicide
Medtech Products Inc.,
Tarrytown, NY 10591,USA
Contr
o
l
Number: 156218
Date of Preparation: June 26, 2012
_Kwellada-P Crèm_
_e Rinse _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_ _
_Page 2 of 14_
TABLE OF
CON
TE
N
TS
PART I: HEALTH
P
R OFESSIONAL
IN
FO
R
MATI
O
N
.....................................................
.
.....
3
SUMMARY PRODUCT
IN
F
O
R
MATIO
N
.
..
....
.
...
........
.
..
..
.
....
.
..
..........
.
........
..
..
.
.
....
.
.
...
..
..
..
.
..
3
INDICATIONS
A
ND
CLINICAL U
S
E
..
.
.
.
..
.
.
.
..
.
..
..
..
.
..
.
..
..
.
....
....
.
.
..
.
..
..
.
..
.
.
.....
.
....
.
.
..
....
..
......
....
.
3
CO
N
T
R
AINDICATIONS
.
.
.
..
.
..
..
.
....
..
..
..
..
..
...
....
.
...
......
.
....
..
..
...
....
.
.
...
.
...
.
.......
..
.
.
.
..
.
.
...
...
.
.
.......
..
3
WARNINGS
AND
PREC
A
U
T
IONS
..
.
..
.
.
.
....
.
..
.
..
..
...
.
..
..
.
.........
..
...
.
...
.
.......
..
..
....
.
..
.
...
.
...
.
......
.
..
.4
DRUG
INTERACTION
S
..
.
..
.
.....
.
.
..
.
..
...
.
..
....
.
...............
.
.....
..
.......
.
..
.
.
...
....
.
..
.
....
....
.
.
....
..
.
..
.....
.
..
.
5
DOSAGE
AND
ADMINISTRATIO
N
.
..
.
..
.....
.
......
....
....
..
....
....
..
....
...
.
..
..
..
.
.......
.
....
..
...
.......
.
.
.
..5
OVERDOSAGE
...
..
..
...
..
.
......
.
..
....
....
..
...
..
.
..
.
.
.....
....
...
.....
..
.
.
...
.
......
.
.
..
....
.
..
..
.
..
.
.
.
........
.
..
...
.....
.
...
6
ACTION AND
CLINICAL
PHAR
MACOLOGY
.
..
.
...
.
..................
.
..
.
........
.
......
.
....
.
..............
6
STORAGE
AND
STABILIT
Y
..
.
..
.
.
..
.
...
...
..
.
..
..
.
....
.
...
..
.
....
...
..
..
.
..
..
.
....
..
..
.
..
.
.
...
..
.
.
..
..
..
...
..
..
..
..
.
.
...
6
DOSAGE FORMS,
COMP
O
S
ITI
O
N
A
ND
PACKAGIN
G
.....
....
..
.
..
.
.
........
..
..
.
.
...
..
..
....
......
.
..
7
PART II: SCIENTIFIC
INFORMATIO
N
.......